Another example is that Tregs were associated with good outcome in B-cell lymphoma when they were identified by Foxp3 alone, but Tregs were associated with poor patient outcome when they were identified by both CTLA-4 and Foxp3 [57]. The gene discussed is FOXP3; the disease is B-cell non-Hodgkin lymphoma.